Antagonistic effects of ABL and BCRABL proteins on proliferation and the response to genotoxic stress in normal and leukemic myeloid cells

Leukemia and Lymphoma

Volumn 30, Issue 3-4, 1998, Pages 225-235

  Guo, X Y D ^a   Fontana, Jason ^a   Kufe, Donald ^b   Deisseroth, Albert ^a  

^a YALE CANCER CENTER   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

ABL; Antagonistic effect; BCRABL proteins; Cell proliferation; Genotoxic stress; Leukemic myeloid cells; Normal cells

Indexed keywords

BCR ABL PROTEIN; ONCOPROTEIN; TRANSCRIPTION FACTOR;

BONE MARROW CELL; CELL CYCLE; CELL PROLIFERATION; CELL TRANSFORMATION; CHRONIC MYELOID LEUKEMIA; GENE MUTATION; GENOTOXICITY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MYELOPOIESIS; ONCOGENE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; STRESS; STRUCTURE ACTIVITY RELATION;

EID: 0031821204     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809057536     Document Type: Review

References (52)

1. Fleming, W. H., Alpern, E. J., Uchida, N., Ikuta, K. and Weissman, I. L. (1993). Steel factor influences the distribution and activity of murine hematopoietic stem cells in vivo. Proc. Natl. Acad. Sci. USA, 90, 3760-3764.
2. Oostendorp, R. A. J., Reisbach, G., Spitzer, E., Thalmeier, K., Deilnemann, H., Mergenthaler, H. and Dormer, P. (1995). VLA-4 and VCAM-1 are the principal adhesion molecules involved in the interaction between blast colony-forming cells and bone marrow stromal cells. Br. J. Haematol., 91, 275-284.
3. Levesque, J. P., Leavesley, D. I., Nuitta, S., Vadas, M. and Simmons, P. J. (1995). Cytokines increase heman hematopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins. J. Exp. Med., 181, 1805-1815.
4. Ogawa, M., Matsuzaki, Y., Nishikawa, S., Hayashi, S-I., Kunisada, T., Sudo, T., Kina, T., Nakauchi, H. and Nishikawa, S-I. (1990). Expression and function of c-kit in hemopoietic progenitor cells. J. Exp. Med., 174, 63-69.
5. Miyazawa. K., Toyama, K., Gotoh, A., Hendrie, P. C., Mantel, C. and Broxmeyer, H. E. (1994). Ligand-dependent polyubiquitination of c-kit gene product: a possible mechanism of receptor down modulation in MO17e cells. Blood, 83, 137-145.
6. Jones, P. H., Harper, S. and Watt, F. M. (1995). Stem cell patterning and fate in the epidermis. Cell, 80, 83-93.
7. Verfaille, C. M. and McGlave, P. B. (1992). Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. J. Clin. Invest., 90, 1232-1241.
8. Gishizky, M. L. (1996). Molecular mechanisms of Bcr-Abl induced oncogenesis. Cytokines and Molecular Therapy, 2, 251-261.
9. Melo, J. V. (1996). The diversity of Bcr-Abl fusion proteins and their relationship to leukemia phenotype. Blood, 88, 2375-2384.
10. McWhirter, J. R., Galasso, D. L. and Wang, J. Y. J. (1993). A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins. Molecular and Cellular Biology, 13, 7587-7595.
11. Pendergast, A. M., Quilliam, L. A., Cripe, L. D., Bassing, C. H., Dai, Z., Li, N., Batzer, A., Rabun, K. M., Der, C. J., Schlessinger, J. and Gishizky, M. L. (1993). Bcr-Abl induced oncogenesis is mediated by direct interaction with the SH2 domain of the Grb-2 adaptor protein. Cell, 75, 175-185.
12. Liu, J. X., Wu, Y., Zhen Ma, G., Lu, D., Haataja, L., Heisterkamp, N., Groffen, J. and Arlinghaus, R. B. (1996). Inhibition of Bcr serine kinase by tyrosine phosphorylation. Molecular and Cellular Biology, 16, 998-1005.
13. Maru, Y. and Witte, O. M. (1991). The Bcr gene encodes a novel serine/threonine kinase activity within a single exon. Cell, 67, 459-468.
14. Boguski, M. S. and McCormick, R. (1993). Proteins regulating Ras and its relatives. Nature, 366, 643-654
15. bcrabl is required for transformation but not growth factor independence. Molecular and Cellular Biology, 13, 1728-1736.
16. Fainstein, E., Einat, M., Gokkcl, E., Marcelle, C., Croce, C. M., Gale, R. P. and Canaani, G. E. (1981). Nucleotide sequence analysis of human Abl and Bcr-Abl cDNAs. Oncogene, 4, 1477-1481.
17. Kharbanda, S., Bharti, A., Pei, D., Wang, J., Pandey, P., Ren., Weichselbaum, R., Walsh, C. T. and Kufe, D. (1996). The stress response to ionizing radiation involves c-Abl dependent phosphorylation of SHPTP1. Proc. Natl. Acad. Sci. USA, 93, 6898-6901.
18. Kufe, D., et al. (1997). Unpublished observations.
19. Van Etten, R. A., Jackson, P. and Baltimore, D. (1989). The mouse type IV c-Abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization. Cell, 58, 669-678.
20. Goga, A., McLaughlkn, J., Pendergast, A. M., Parmar, K., Muller, A., Rosenberg, N. and Witte, O. M. (1993). Oncogenic activation of c-Abl within its last exon. Molecular and Cellular Biology, 13, 4967-4975.
21. Kipreos, E. T. and Wang, J. Y. J. (1992). Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA. Science, 256, 382-385.
22. Jackson, P. K., Paskind, M. and Baltimore, D. (1993). Mutation of a phenylalanine conserved in SH3-containing tyrosine kinases activates the transforming ability of c-Abl. Oncogene, 8, 1943-1956.
23. Welch, P. J. and Wang, J. Y. J. (1995). Abrogation of retinoblastoma protein function by c-Abl through tyrosine kinase-dependent and -independent mechanisms. Molecular and Cellular Biology, 15, 5542-5551.
24. Welch, P. J. and Wang, J. Y. J. (1993). A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell, 75, 779-790.
25. Shi, Y., Alin, K. and Goff, S. P. (1995). Abl-interactor-1. a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-Abl transforming activity. Genes and Development, 9, 2583-2597.
26. Dai, Z. and Pendergast, A. M. (1995). Abi-2. a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity. Genes and Development, 9, 2569-2582.
27. Kipreos, E. T. and Wang, J. Y. J. (1994). Differential phosphorylation of c-Abl in cell cycle determined by cdc 2 kinase and phosphatase activity. Science, 248, 217-220.
28. Ren, R., Ye, Z. S. and Baltimore, D. (1994). Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites. Genes Dev, 8, 783-795.
29. Duyster, J., Baskaran, R. and Wang, J. Y. J. (1995). Src homology 2 domain as a specificity determinant in the c-Abl mediated tyrosine phosphorylation of the RNA polymerase II carboxyl-terminal repeated domain. Proc. Natl. Acad. Sci. USA, 92, 1555-1559.
30. Cortez, D., Kadlec, L. and Pendergast, A. M. (1995). Structural and signaling requirements for Bcr-Abl mediated transformation and inhibition of apoptosis. Molecular and Cellular Biology, 15, 5531-5541.
31. Gishizky, J. L., Cortez, D. and Pendergast, A. M. (1995). Mutant forms of growth factor binding protein-2 reverse Bcr-Abl induced transformation. Prof. Natl. Acad. Sci. USA, 92, 10889-10893.
32. Raitano, A. B., Hallpern, J. R., Hambuch, T. M. and Sawyers, C. L. (1995). The Bcr-Abl leukemia oncogene activates Jun kinasc and requires Jun for transformation. Proc. Natl. Acad. Sci. USA, 92, 11746-11750.
33. Muller, A. J., Pendergast, A. M., Parmar, K., Mavlik, M. H., Rosenberg, M. and Witte, O. N. (1993). En bloc substitution of the Src homology region 2 domain activates the transforming potential of the c-Abl protein tyrosine kinase. Proc. Natl. Acad. Sci. USA, 90, 3457-3461.
34. Franz, W. M., Berger, P. and Wang, J. Y. J. (1989). Deletion of an n-terminal regulatory domain of the c-Abl tyrosine kinase activates its oncogenic potential. EMBO J, 8, 137-147.
35. Papadopoulos, P., Ridge, S. A., Boucher, C. A., Stocking, C. and Wiedemann, L. M. (1995). The novel activation of Abl by fusion to an ets-related gene, TEL. Cancer Res., 55, 34-38.
36. Wen, S. T., Jackson, R. K. and Van Etter, R. A. (1995). The cytostatic function of c-Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb suppressor gene products. EMBO J, 15, 1583-1595.
37. Kharbanda, S., Ren, R., Pandeyk, P., Shafman, R. D., Feller, S. M., Welchselbaum, R. R. and Kufe, D. W. (1995). Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature, 376, 785-788.
38. Yuan, Z. M., Huang, Y. Y., Whang, Y., Sawyers, C., Weichselbaum, R., Kharbanda, S. and Kufe, D. (1996). Role for c-Abl tyrosine kinase in growth arrest response to DNA damage. Nature, 382, 272-274.
39. Kharbanda, S., Pandey, P., Jin, S., Bharti, A., Yuan, Z. M., Weichselbaum, R., Weaver, D. and Kufe, D. (1997). Functional interaction of DNA-PK and c-Abl in response to DNA damage. Nature, In press.
40. bcrabl to the phosphatidylinositol-3′ kinase pathway. Oncogene, 12, 839-846.
41. Feller, S. M., Knudsen, B. and Hanafusa, H. (1994). c-Abl kinase regulates the protein hinding activity of c-Crk. EMBO J, 13, 2341-2351.
42. Xia, Z., Dickens, M., Raingcaud, J., Davis, R. J. and Greenberg, M. E. (1995). Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science, 270, 1326-1331.
43. Hartley, K. O., Gell, D., Smith, G. C. M., Zhang, H., Divecha, N., Connelly, M. A., Admon, A., Lees-Miller, S. P. and Anderson, C. W. (1995). DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-1kinase and the Ataxia Telangicctasia Gene Product. Cell, 82, 849-856.
44. Kufe, D., et al. (1994). Unpublished observations.
45. Knudsen, E. X. and Wang, J. Y. J. (1996). Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites. J. B. C., 271, 8313-8320.
46. c subunit and constitutively induces its tyrosine phosphorylation. Cancer Research, 56, 3426-3430.
47. Bazzoni, G., Carlesso, M., Griffin, J. and Hemier, M. E. (1997). Bcr/Abl expression stimulates integrin function in hematopoietic cell lines. Journal of Clinical Investigation, 98, 521-528.
48. cchl. Experimental Hematology, 24, 310-313.
49. bcrabl. Oncogene, 11, 1149-1155.
50. Carlesso, N., Frank, D. A. and Griffin, J. D. (1996). Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J. Exp. Med., 183, 811-820.
51. Henderson, Y. C., Guo, X. Y. D., Greenberger, J. and Deisseroth, A. (1993). Potential role of Bcr-Abl in the activation of JAK I kinase. Clinical Cancer Research, 3, 145-150.
52. Yuan, Z. M., Utsugisawa, T., Huang, Y. Y., Ishiko, T., Nakada, S., Kharbanda, S., Weicheselbaum, R., and Kufe, D. Inhibition of Phosphatidylinositol 3-kinase by c-abl in The Genotoxic Stress Response. J. Biol. chem. 272, 1997 in press.